跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
CLARISCAN gadoteric acid 1.397g/5mL solution for injection vial
Approved
STANDARD
CLARISCAN gadoteric acid 1.397g/5mL solution for injection vial
GE Healthcare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
691f0d90d033691b
Company
GE Healthcare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
691f0d90d033691b
Product Name
CLARISCAN gadoteric acid 1.397g/5mL solution for injection vial
Artg Id
284859
Artg Name
CLARISCAN gadoteric acid 1.397g/5mL solution for injection vial
Sponsor
GE Healthcare Australia Pty Ltd
Company Detail Path
/organization/ge-healthcare-australia-pty-limited
Artg Date
2018-01-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5354d30bcddc64ed7da7ca9d8c2b7d45.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dac16cf0abfce5ed260b36b685f476ce.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
691f0d90d033691b
Type
Standard
Back to TGA Approvals
CLARISCAN gadoteric acid 1.397g/5mL solution for injection vial - TGA Drug Approval Details
